10
BCR-ABL1 TKD mutations
CML AK Book
Preface
1
Introduction
2
TKIs for CML
3
Dasatinib
4
Asciminib
5
ELVN-001
6
TERN-701 CARDINAL Phase 1 Study Analysis
7
TGRX-678 Phase 1 Study Analysis: Efficacy in CML Patients with T315I Mutation
8
Olverembatinib
9
Additional Mutations in CML
10
BCR-ABL1 TKD mutations
11
Guideline Recommendations in CML
12
TKI Discontinuation
13
HSCT for CML
14
Summary
References
Table of contents
11
When to test for BCR:ABL1 TKD mutation testing during therapy
10
BCR-ABL1 TKD mutations
11
When to test for BCR:ABL1 TKD mutation testing during therapy
ELN 2023 Recommendations
(
Cross et al. 2023
)
Cross, Nicholas C. P., Thomas Ernst, Susan Branford, et al. 2023.
“European LeukemiaNet Laboratory Recommendations for the Diagnosis and Management of Chronic Myeloid Leukemia.”
Leukemia
37 (11): 2150–67.
https://doi.org/10.1038/s41375-023-02048-y
.
9
Additional Mutations in CML
11
Guideline Recommendations in CML